Sunday, April 25th, 2021
11:00 - 13:45
Poster Discussion
Poster Session 4 - TREATMENT OF THROMBOSIS
Poster Session 5 - EPIDEMIOLOGY II
Poster Session 6 - THERAPEUTIC CHALLENGES
Poster Session 7 - HEMOSTATIC SYSTEM/TUMOR BIOLOGY INTERACTIONS
15:00 – 16:45
Plenary Session 4: Bench to Bedside: New insights Into Hemostasis and Cancer
Chairs: P.M. Sandset (Norway), R. Giavazzi (Italy)
PL-14 - Genetic and epigenetic regulation of cancer coagulome - lessons from heterogeneity of cancer cell populations
J. Rak (Canada)
PL-15 - Coagulation signaling and cancer immuno-therapy
W. Ruf (Germany)
PL-16 - Heparanase-revisited
Y. Nadir (Israel)
PL-17 - Cancer Animal Models in Thrombosis Research
C. Dubois (France)
PL-18 - The thrombin-inflammation axis in cancer progression
J. Palumbo (USA)
Selected Abstract
OC-10 - Thrombin Tips the Scales towards Effective Immune Checkpoint Blockade in Cancer
R. Cantrell, L. Rosenfeldt, D. Mureb, M. Lehn, B.K. Sharma, A. Revenko, B. Monia, E. Janssen, J.S. Palumbo (USA)
OC-11 - Plasminogen activator inhibitor 1 enhances venous thrombosis in pancreatic cancer
Y. Hisada, K.B. Garratt, A. Maqsood, S.P. Grover, T. Kawano, B.C. Cooley, J. Erlich, F. Moik, M.J. Flick, I. Pabinger, N. Mackman, C. Ay (USA - Austria)
16:45 – 17:15
Debate: Outpatient prophylaxis: are we there yet?
Chairs: G. Agnelli (Italy), C. Francis (USA)
NO: F. Klok (The Netherlands)
YES: A.A. Khorana (USA)
17:15 – 18:45
Plenary Session 5: Prevention of VTE in cancer patients
Chairs: P. Prandoni (Italy), J.A. Paramo (Spain)
PL-14 - Inpatient thromboprophylaxis in cancer patients: what is the evidence?
J. Zwicker (USA)
PL-15 - Roles of LMWH for prevention in cancer patients
A. Maraveyas (UK)
PL-16 - Meta-analysis and systematic review of NOAC prophylaxis in high risk cancer outpatients
N. Kuderer (USA)
Selected Abstract
OC-12 - D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial
S. Vadhan-Raj, N. Kuderer, T. Wun, J. Patel, K. McCrae, X. Zhou, U. Vijapurkar, C.V. Damaraju, P. Wildgoose, G. Lyman, A.A. Khorana (USA)
OC-13 - A clinical-genetic risk score to predict cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
A. Muñoz, C. Ay, E. Grilz, S. López, C. Font, V. Pachón, V. Castellón, V. Martínez-Marín, M. Salgado, E. Martínez, J. Calzas, A. Rupérez, E. Salas, I. Pabinger, J.M. Soria (Spain, Austria)